Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Liver Cancer |
| Online Access: | https://karger.com/article/doi/10.1159/000545594 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849727618681667584 |
|---|---|
| author | Masatoshi Kudo |
| author_facet | Masatoshi Kudo |
| author_sort | Masatoshi Kudo |
| collection | DOAJ |
| format | Article |
| id | doaj-art-5d8d5efc22144ece9664883b2792b6f9 |
| institution | DOAJ |
| issn | 1664-5553 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Liver Cancer |
| spelling | doaj-art-5d8d5efc22144ece9664883b2792b6f92025-08-20T03:09:48ZengKarger PublishersLiver Cancer1664-55532025-01-0114324124710.1159/000545594Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial ResultsMasatoshi Kudohttps://orcid.org/0000-0002-4102-3474https://karger.com/article/doi/10.1159/000545594 |
| spellingShingle | Masatoshi Kudo Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results Liver Cancer |
| title | Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results |
| title_full | Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results |
| title_fullStr | Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results |
| title_full_unstemmed | Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results |
| title_short | Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results |
| title_sort | immune checkpoint inhibitor plus anti vegf tki combined with transarterial chemoembolization in locally advanced nonmetastatic hepatocellular carcinoma real world treatment strategy based on phase 3 clinical trial results |
| url | https://karger.com/article/doi/10.1159/000545594 |
| work_keys_str_mv | AT masatoshikudo immunecheckpointinhibitorplusantivegftkicombinedwithtransarterialchemoembolizationinlocallyadvancednonmetastatichepatocellularcarcinomarealworldtreatmentstrategybasedonphase3clinicaltrialresults |